The ‘Grassroots Campaign’ for ‘Female Viagra’ Was Actually Funded by Its Manufacturer

September 9, 2016

(New York Magazine) – Last August, the FDA delivered its approval, overturning its own internal reviewers’ recommendations. In an editorial accompanying the recent JAMA review, Steven Woloshin and Lisa Schwartz, physician-researchers at Dartmouth Medical School and the founders of pharmaceutical education company Informulary, wrote that FDA administrators “overrode” scientists’ evaluations that the drug didn’t warrant approval. “When we looked at the new data for Addyi, it was hard to understand why the drug was approved the third time around because there was a new alarming drug interaction study — so alarming that it was stopped early because so many people had low blood pressure or fainted,” Schwartz said.